- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Waters Corporation (WAT)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/17/2025: WAT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $405.34
1 Year Target Price $405.34
| 6 | Strong Buy |
| 1 | Buy |
| 15 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -1.17% | Avg. Invested days 42 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 22.45B USD | Price to earnings Ratio 34.85 | 1Y Target Price 405.34 |
Price to earnings Ratio 34.85 | 1Y Target Price 405.34 | ||
Volume (30-day avg) 22 | Beta 1.16 | 52 Weeks Range 275.05 - 423.56 | Updated Date 12/17/2025 |
52 Weeks Range 275.05 - 423.56 | Updated Date 12/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 10.82 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.89% | Operating Margin (TTM) 27.39% |
Management Effectiveness
Return on Assets (TTM) 11.53% | Return on Equity (TTM) 32.99% |
Valuation
Trailing PE 34.85 | Forward PE 26.6 | Enterprise Value 23562732132 | Price to Sales(TTM) 7.23 |
Enterprise Value 23562732132 | Price to Sales(TTM) 7.23 | ||
Enterprise Value to Revenue 7.59 | Enterprise Value to EBITDA 22.57 | Shares Outstanding 59534740 | Shares Floating 59419243 |
Shares Outstanding 59534740 | Shares Floating 59419243 | ||
Percent Insiders 0.16 | Percent Institutions 100.3 |
About Waters Corporation
Exchange NYSE | Headquaters Milford, MA, United States | ||
IPO Launch date 1995-11-16 | President, CEO & Director Dr. Udit Batra Ph.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 7600 | Website https://www.waters.com |
Full time employees 7600 | Website https://www.waters.com | ||
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

